Viewing Study NCT00441064



Ignite Creation Date: 2024-05-05 @ 5:24 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00441064
Status: COMPLETED
Last Update Posted: 2011-03-25
First Post: 2007-02-26

Brief Title: Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren
Sponsor: Novartis
Organization: Novartis

Study Overview

Official Title: A Randomized Open-label Blinded Endpoint Multi-center Cross-over Study to Evaluate the Effect of High and Low Sodium Diets on Reduction in Mean 24-hour Ambulatory Blood Pressure in Systolic Hypertensive Patients Treated With Aliskiren 300 mg
Status: COMPLETED
Status Verified Date: 2011-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will compare the effects of high and low level sodium salt diets on blood pressure in patients with hypertension high blood pressure who are taking aliskiren 300 mg
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None